Hemolytic-Uremic Syndrome clinical trials at University of California Health
2 in progress, 1 open to eligible people
Showing trials for
Hyperhydration in Children With Shiga Toxin-Producing E. Coli Infection
open to eligible people ages 9 months to 21 years
The objective of this study is to determine if early high volume intravenous fluid administration (hyperhydration) may be effective in mitigating or preventing complications of shiga toxin-producing E. coli (STEC) infection in children and adolescents when compared with traditional approaches (conservative fluid management).
at UC Davis UCSD
Pharmacodynamics of Crovalimab in Adult and Adolescent Participants With Atypical Hemolytic Uremic Syndrome (aHUS)
Sorry, in progress, not accepting new patients
This study aims to evaluate the efficacy and safety of crovalimab in adult and adolescent participants with aHUS.
at UCSF
Last updated: